Recent Advancements in Natural Products Research for the Treatment and Prevention of Solid Tumors
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: closed (31 August 2024) | Viewed by 4408
Special Issue Editor
Special Issue Information
Dear Colleagues,
Although natural products have long been recognized for their potential benefits, recent advancements have led to a renewed interest in exploring their therapeutic potential in various diseases, including cancer.
Solid tumors are abnormal masses of cancerous tissues that can occur in the bones, tissues or organs. While several attempts such as chemotherapy, targeted therapy, and immunotherapy have been made throughout hiwstory to battle cancer, a perfect treatment for solid tumors is yet to be discovered.
To find a safe and effective way to treat solid tumors, we should extensively understand their nature. Solid tumors are heterotypic aggregates of cancer cells, cancer stem cells, connective-tissue cells, endothelial cells and immune cells. These cells communicate to maintain an ecosystem known as the tumor microenvironment. Natural products have always been an attractive source of anticancer drugs since they are capable to regulate multiple hallmark traits of not only cancer cells, but the surrounding microenvironment as well.
In this Special Issue, we aim to publish high-quality evidence-based research on the potential of natural products in treating and preventing solid tumors. We welcome both original articles and reviews.
Dr. Hyo In Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- phytochemicals
- cancer
- solid tumor
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
